Eqis Capital Management, Inc. Zimmer Biomet Holdings, Inc. Transaction History

Eqis Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$102.72 - $121.7 $44,683 - $52,939	435 Added 23.34%	2,299 $279,000
Q3 2023 Nov 13, 2023	SELL	$110.76 - $143.18 $31,345 - $40,519	-283 Reduced 13.18%	1,864 $209,000
Q2 2023 Aug 14, 2023	BUY	$126.43 - $145.6 $271,445 - $312,603	2,147 New	2,147 $312,000
Q1 2018 Apr 06, 2018	SELL	$104.31 - $124.46 $324,508 - $387,195	-3,111 Closed	0 $0
Q4 2017 Jan 25, 2018	BUY	$105.55 - $120.83 $328,366 - $375,902	3,111	3,111 $375,000

1,080

179M

301K

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $22.7B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.